🇺🇸 FDA

Intelligence · Patent portfolio

RIGEL PHARMACEUTICALS Patents

Full USPTO pharma patent portfolio for RIGEL PHARMACEUTICALS — grant dates, expiration, and drug cross-links.

Patents
373
Expiring ≤24m
18

Quick answer

RIGEL PHARMACEUTICALS has 373 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 18 expire within 24 months — use filters for patent-cliff planning.

Page 8 of 8

  1. US 7422867

    Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein

    Expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7420045

    IAPs associated cell cycle proteins, compositions and methods of use

    Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7413870

    SAK: modulation of cellular proliferation for treatment of cancer

    Expires Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7410979

    Synergistically effective combinations of dihaloacetamide compounds and interferon or ribavirin against HCV infections

    Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7378251

    Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a thioredoxin-like 32 kDa protein

    Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7368257

    Modulators of lymphocyte activation, Mkk3b compositions and methods of use

    Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7358259

    HCV inhibitors and methods of using them

    Expires Mon Apr 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7332484

    2,4-pyrimidinediamine compounds and their uses

    Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7332602

    Pyridyl substituted heterocycles useful for treating or preventing HCV infection

    Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7329672

    2,4-pyrimidinediamine compounds and their uses

    Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7329671

    2,4-pyrimidinediamine compounds and their uses

    Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7326790

    Diphenylisoxazole compounds and hydro isomers thereof

    Expires Mon Jan 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7285383

    Method for selective inactivation of viral replication

    Expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7244576

    Modulators of angiogenesis

    Expires Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7241581

    Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a c-MYC protein

    Expires Mon Jul 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7220745

    Heterocyclic compounds useful to treat HCV

    Expires Mon May 17 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7208289

    Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein

    Expires Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7157473

    Pyridyl substituted heterocycles useful for treating or preventing HCV infection

    Expires Mon Dec 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7153880

    Substituted diphenyl heterocycles useful for treating HCV infection

    Expires Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7141434

    Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing an adenosine kinase

    Expires Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7122542

    Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

    Expires Mon Oct 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7060827

    Intermediates useful for making 2,4-pyrimidinediamine compounds

    Expires Mon Jun 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7045284

    Method for selective inactivation of viral replication

    Expires Mon May 11 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  24. US 6979549

    Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a CLLD8 protein

    Expires Mon Dec 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  25. US 6946247

    RNAse probe protection assays in screening for modulators of immunoglobulin germline transcription

    Expires Mon Sep 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  26. US 6887675

    Tankyrase H, compositions involved in the cell cycle and methods of use

    Expires Mon Apr 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  27. US 6824976

    Method for selective inactivation of viral replication

    Expires Mon Nov 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  28. US 6777179

    Method for selective inactivation of viral replication

    Expires Mon Aug 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  29. US 6759538

    Substituted diphenyl heterocycles useful for treating HCV infection

    Expires Mon Jul 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  30. US 6737232

    IAPs associated cell cycle proteins, compositions and methods of use

    Expires Mon May 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  31. US 6696263

    PCNA associated cell cycle proteins, compositions and methods of use

    Expires Mon Feb 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  32. US 6667152

    Method for selective inactivation of viral replication

    Expires Mon Dec 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  33. US 6623961

    Method for selective inactivation of viral replication

    Expires Mon Sep 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  34. US 6617102

    Tankyrase H, compositions involved in the cell cycle and methods of use

    Expires Mon Sep 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  35. US 6589725

    Tankyrase H, compositions involved in the cell cycle and methods of use

    Expires Mon Jul 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  36. US 6579674

    Method for selective inactivation of viral replication

    Expires Mon Jun 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  37. US 6387658

    PCNA-associated cell cycle proteins, compositions and methods of use

    Expires Mon May 09 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does RIGEL PHARMACEUTICALS have?

373 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do RIGEL PHARMACEUTICALS patents expire?

18 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.